Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 724 participants.

Also called NCT07762547

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 724 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07762547
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07762547. Randomized; quadruple masking; primary purpose treatment. Start 2026-07-15 (anticipated); primary completion 2030-02-28 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.
Acronym
MOUNT-EASE
Condition
Moyamoya Disease
Condition
Moyamoya Syndrome
Condition
Aspirin
Condition
Remote Ischemic Conditioning
Intervention (Drug)
aspirin treatment
Intervention (Drug)
Aspirin placebo
Intervention (Device)
Remote Ischemic Conditioning
Intervention (Device)
Sham remote ischemic conditioning
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct07762547
Content hash
c814ff17c119b5473fd44ed027ecd346923b2ccae66f067cfb813d5143f48152